|
gptkbp:instance_of
|
gptkb:biotechnology
|
|
gptkbp:acquired_by
|
gptkb:Takeda_Pharmaceutical_Company
|
|
gptkbp:ceo
|
gptkb:Dr._David_Schenkein
|
|
gptkbp:defunct
|
gptkb:2017
|
|
gptkbp:focus
|
gptkb:cancer_treatment
|
|
gptkbp:founded
|
gptkb:1991
|
|
gptkbp:founder
|
Harold Shlevin
|
|
gptkbp:headquarters
|
gptkb:Cambridge,_Massachusetts
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ariad Pharmaceuticals
|
|
gptkbp:industry
|
gptkb:pharmaceuticals
|
|
gptkbp:key_people
|
gptkb:Dr._David_Schenkein
|
|
gptkbp:location
|
gptkb:United_States
|
|
gptkbp:notable_products
|
gptkb:Iclusig
|
|
gptkbp:partnership
|
gptkb:Sutro_Biopharma,_Inc.
gptkb:Incyte_Corporation
gptkb:Medi_Wound_Ltd.
gptkb:Celyad
gptkb:Celgene_Corporation
gptkb:biotechnology
gptkb:Johnson_&_Johnson
gptkb:Zymeworks
gptkb:Roche_Holding_AG
gptkb:Immunomedics
gptkb:Nant_Kwest,_Inc.
gptkb:Alder_Bio_Pharmaceuticals,_Inc.
gptkb:Kite_Pharma
gptkb:Medi_Wound
gptkb:Merck_KGa_A
gptkb:Novartis_AG
gptkb:Astra_Zeneca
gptkb:Abb_Vie_Inc.
gptkb:Astra_Zeneca_PLC
gptkb:Sanofi
gptkb:Bristol-Myers_Squibb
gptkb:Sutro_Biopharma
gptkb:Pfizer
gptkb:Pfizer_Inc.
gptkb:Apexigen
gptkb:Regeneron_Pharmaceuticals
gptkb:Karyopharm_Therapeutics
gptkb:Merck_&_Co.
gptkb:Regeneron_Pharmaceuticals,_Inc.
gptkb:Roche
gptkb:Gilead_Sciences,_Inc.
gptkb:Amgen_Inc.
gptkb:Bristol-Myers_Squibb_Company
gptkb:Johnson_&_Johnson_Services,_Inc.
gptkb:Mirati_Therapeutics
gptkb:Amgen
gptkb:Apexigen,_Inc.
gptkb:Blueprint_Medicines
gptkb:Gilead_Sciences
gptkb:Sorrento_Therapeutics,_Inc.
gptkb:Zymeworks_Inc.
gptkb:Kite_Pharma,_Inc.
gptkb:Eli_Lilly_and_Company
gptkb:Sorrento_Therapeutics
gptkb:Vertex_Pharmaceuticals
gptkb:Abb_Vie
gptkb:Celgene
gptkb:Immuno_Gen
gptkb:Onco_Sec_Medical
gptkb:Cure_Vac_AG
gptkb:Cure_Vac
gptkb:Novartis
gptkb:Alder_Bio_Pharmaceuticals
gptkb:Nant_Kwest
gptkb:TCR2_Therapeutics
gptkb:Aduro_Biotech,_Inc.
gptkb:Adaptimmune_Therapeutics
gptkb:Cure_Vac_N._V.
gptkb:Immuno_Gen,_Inc.
gptkb:Immunomedics,_Inc.
gptkb:Karyopharm_Therapeutics_Inc.
gptkb:Mirati_Therapeutics,_Inc.
gptkb:Sanofi_S._A.
gptkb:Tessa_Therapeutics
gptkb:Tessa_Therapeutics_Pte_Ltd.
gptkb:TCR2_Therapeutics_Inc.
Adaptimmune Therapeutics PLC.
Blueprint Medicines Corporation.
Celyad SA.
Cure Vac AG.
Eli Lilly and Company.
Incyte Corporation.
Onco Sec Medical Incorporated.
Vertex Pharmaceuticals Incorporated.
|
|
gptkbp:product
|
Iclusig (ponatinib)
AP24534
AP26113
AP32788
|
|
gptkbp:research_focus
|
targeted therapies
|
|
gptkbp:service
|
oncology
|
|
gptkbp:subsidiary
|
gptkb:Ariad_Pharmaceuticals,_Inc.
|
|
gptkbp:traded_on
|
gptkb:NYSE
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
www.ariad.com
|
|
gptkbp:bfsParent
|
gptkb:Astra_Zeneca
|
|
gptkbp:bfsLayer
|
4
|